Empress Therapeutics

Empress Therapeutics is working to discover new medicines at unprecedented speed and scale. The two major limitations in drug development are time and uncertainty. Using their ChemilogicsTM platform, Empress is integrating patient data, DNA, AI and synthetic biology to find better starting points for drugs. This proprietary set of technologies uses the power of the genetic code to rapidly and predictably turn programmable chemistries into novel small molecular medicines. Currently, Empress has discovered more than a dozen small molecules with proven pharmaceutical properties which offer new therapies to treat immune and inflammatory diseases.

Jobs: